We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Common Stock (QB) | USOTC:QSAM | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16,600.00 | 8.23 | 8.35 | 0.00 | 01:00:00 |
QSAM Biosciences, Inc.
9442 Capital of Texas Hwy N. Plaza 1, Suite 500
Austin, Texas 78759
May 16, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: | QSAM Biosciences, Inc. | |
Request to Withdraw Registration Statement on Form S-1 | ||
File No. 333-261735 |
Ladies and Gentlemen:
Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), QSAM Biosciences, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of the Company’s Registration Statement on Form S-1 together with all exhibits and amendments thereto (collectively, the “Registration Statement”). The Registration Statement was originally filed with the Commission on December 17, 2021.
The grounds upon which the Company is making this application for withdrawal are that the Company does not intend to proceed with the planned registered offering of its shares of common stock and warrants under the Registration Statement at this time due to prevailing market conditions. The Registration Statement has not been declared effective by the Commission, and no securities were sold or will be sold under the Registration Statement. Therefore, withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by paragraph (a) of Rule 477 under the Securities Act.
The Company requests that, in accordance with Rule 457(p) under the Securities Act, all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use.
Additionally, the Company requests that the Commission consent to withdrawal of the Company’s registration statement on Form 8-A12B (File No. 001-41337), filed with the Commission on March 28,2022, and declared effective on March 29, 2022.
Please do not hesitate to contact Joel D. Mayersohn at 954-994-5426 or jmayersohn@dickinsonwright.com if you have any questions regarding the foregoing or if we can provide any additional information.
Very truly yours, | |||
QSAM BIOSCIENCES, INC. | |||
By: | /s/ Douglas Baum | ||
Name: | Douglas Baum | ||
Title: | Chief Executive Officer | ||
cc: | Joel D. Mayersohn, Esq |
1 Year Common Stock (QB) Chart |
1 Month Common Stock (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions